The clinical stakes are considerable. Sputum culture conversion, defined as two consecutive negative cultures collected at least 30 days apart, is a critical early indicator of treatment efficacy and a predictor of long-term cure. Patients whose cultures remain positive at the two-month mark face a higher risk of treatment failure, relapse, and continued transmission within their communities. The World Health Organization’s End TB Strategy, which aims to dramatically reduce tuberculosis incidence by 2035, depends on improving these unfavourable outcomes, yet the immunological mechanisms governing sputum conversion have remained poorly understood. Host-pathogen interactions in tuberculosis are notoriously heterogeneous, with significant variation between patients in radiographic presentation, symptoms, and disease trajectory, making it difficult to predict who will respond and who will not.

To probe this heterogeneity at unprecedented resolution, the research team enrolled eight patients with confirmed drug-sensitive Mycobacterium tuberculosis infection, dividing them into four treatment responders and four non-responders based on their two-month sputum culture conversion status. The researchers isolated peripheral blood mononuclear cells and subjected them to single-cell RNA sequencing using the 10x Genomics Chromium X platform, sequencing on an Illumina NovaSeq X Plus instrument. After rigorous quality control, 83,999 cells were retained for analysis, with an average of 1,723 genes detected per cell. Unsupervised clustering resolved the data into 17 transcriptional clusters, which the team annotated into six major immune cell types: T cells, NK cells, B cells, myeloid cells, mast cells, and platelets.

The most striking finding emerged from the myeloid compartment. Non-classical monocytes, a subset of monocytes characterized by their patrolling behaviour in the vasculature, were relatively enriched in the non-responder group and carried elevated scores on a previously established tuberculosis progression risk signature. The total monocyte fraction showed a large standardized between-group difference, with a Cohen’s d of 1.04, although the authors caution that with only four patients per group this effect size is descriptive rather than definitive. Trajectory analyses using PAGA and Monocle, combined with CytoTRACE differentiation scoring, indicated that these non-classical monocytes were terminally differentiated, and SCENIC regulatory network analysis highlighted activation of transcription factors including ZNF177, FOXP3, and HES5 within the subset.

The transcriptional programs of these cells diverged sharply between groups. Non-classical monocytes from non-responders showed upregulation of TLR6, TLR1, IFI44, and PARP9, and were enriched for pathways involving Toll-like receptor 2 signalling, type II interferon-mediated signalling, and negative regulation of cytokine signalling through I-kappa-B kinase and NF-kappa-B pathways. In contrast, the corresponding cells from responders expressed higher levels of LAPTM5, CXCL8, and PTGS2 and were associated with cell adhesion and positive regulation of cytokine-mediated signalling. Monocytes from non-responders also displayed elevated expression of GBP2, STAT1, and TAP1, genes previously proposed as candidate biomarkers of tuberculosis infection. Taken together, these signatures suggest that non-classical monocytes in non-responders are locked into a terminally differentiated, senescence-like state biased towards innate inflammatory activation, echoing earlier reports that linked the pro-inflammatory phenotype of this subset to cellular senescence driven by NF-kappa-B and IL-1 alpha signalling.

Perhaps the most conceptually intriguing result came from CellChat-based intercellular communication analysis, which models how cell populations signal to one another through known ligand-receptor pairs. In non-responders, non-classical monocytes received more incoming signals but emitted fewer outgoing signals than their counterparts in responders, effectively behaving as signalling sinks rather than active communicators. The analysis identified the IL16 and TRAIL, encoded by TNFSF10, pathways among the upregulated inferred interactions involving non-responder non-classical monocytes, classical monocyte subsets, and CD4-positive T cells. The authors are careful to frame these findings as transcriptomic ligand-receptor hypotheses rather than demonstrations of protein secretion or causal signalling, but the pattern resembles the behaviour of exhausted or senescent cells that accumulate inhibitory inputs while failing to respond effectively, a phenomenon previously described in severe tuberculosis where CD14-positive CD16-positive monocytes correlate with T-cell inhibition and immune paralysis.

The study also documented profound changes in the lymphocyte compartment. Overall T cell abundance was reduced in non-responders, yet subclustering revealed a significant expansion of CD8-positive cytotoxic T cells alongside CD4-positive regulatory T cells with stronger inhibitory profiles. Exhaustion-associated markers told a consistent story: HAVCR2, which encodes the TIM-3 checkpoint receptor, was broadly elevated in non-responders, particularly in cytotoxic T cells and regulatory T cells, while TIGIT showed more restricted expression in the same subsets. Critically, LGALS9, the ligand for TIM-3, was significantly upregulated in regulatory T cells from non-responders, and CellChat inferred LGALS9-dependent interactions, including LGALS9-P4HB, LGALS9-CD45, and LGALS9-CD44, primarily targeting CD8-positive cytotoxic T cells. At the single-cell level, LGALS9 expression correlated positively with HAVCR2 in non-responders, with a correlation coefficient of 0.471, whereas the corresponding association in responders was weaker and statistically non-significant, and a similar group-specific pattern held for TIGIT.

Innate lymphocytes were not spared. NK cell subclustering identified immature and mature subsets, with NKT cells more abundant in non-responders and a mature NK subcluster showing clear spatial separation between groups. CellChat inferred stronger GALECTIN signalling, including LGALS9-HAVCR2 interactions, from regulatory T cells to this mature NK subset in non-responders, and the affected cells displayed higher HAVCR2 and TIGIT expression alongside reduced CCL5 and CXCR4, with pseudotime analysis placing them towards the terminal end of the inferred differentiation trajectory. To contextualize these cross-sectional findings temporally, the team reanalyzed the public microarray dataset GSE40553 using CIBERSORT deconvolution, which suggested that estimated non-classical monocyte proportions decline after two months of anti-tuberculosis therapy and remain low through twelve months. The authors emphasize that this bulk-transcriptome analysis provides descriptive temporal context only and cannot validate the single-cell-defined functional states or test individual conversion outcomes.

An exploratory in silico layer added further hypothesis-generating depth. Virtual knockout analysis using scTenifoldKnk predicted that perturbing IL16 would disturb 24 genes and TNFSF10 would disturb 34 genes at false discovery rate significance, with representative affected genes including TCF7, IL7R, and CCR7 for IL16, and NKG7, PRF1, and GNLY for TNFSF10, pointing towards consequences for T cell and cytotoxic lymphocyte function. Ninety perturbation-associated genes were shared between the two analyses and were enriched for cellular defence response and response to molecules of bacterial origin. The authors stress that these computational results prioritize candidates for experimental study but do not establish gene function, protein effects, or therapeutic benefit.

The authors are admirably forthright about the limitations of their work. With eight patients in total, four per group, the study lacks the statistical power for definitive conclusions, and no protein measurements of IL16, TNFSF10, or LGALS9 were performed, nor were experimental gene perturbations conducted. Trajectory inference methods are sensitive to sampling density and modelling assumptions, making the terminal differentiation interpretation provisional, and observational cross-sectional data cannot determine whether the observed immune changes are causes or consequences of persistent infection. Nevertheless, the study nominates non-classical monocyte composition and IL16 and TNFSF10-related transcripts as candidate biomarkers worthy of prospective validation, and proposes a testable network model in which dysregulated monocyte signalling coexists with regulatory T cell-mediated galectin signalling and exhaustion features in cytotoxic lymphocytes. If larger cohorts with protein-level measurements and functional assays confirm these associations, the findings could open the door to host-directed therapies or early immunological monitoring that identifies at-risk patients before treatment failure becomes entrenched, a development that would materially advance the global effort to bring tuberculosis under control.

Subject of Research: Single-cell immune profiling of tuberculosis patients to identify immunological determinants of sputum culture conversion and treatment response

Article Title: Single‐Cell Immune Profiling Suggests Non‐Classical Monocyte Is Associated Immunodepression in Tuberculosis Treatment Non‐Responders

Article References: Single‐Cell Immune Profiling Suggests Non‐Classical Monocyte Is Associated Immunodepression in Tuberculosis Treatment Non‐Responders. (n.d.). https://doi.org/10.1111/jcmm.71345

Image Credits: AI Generated

DOI: 10.1111/jcmm.71345

Keywords: tuberculosis, single-cell RNA sequencing, non-classical monocytes, sputum culture conversion, immune suppression, IL16, TNFSF10, LGALS9, regulatory T cells, treatment non-responders, immunodepression, host-directed therapy

The research team, led by Chai et al., mapped the spatial transcriptome of macrophage and T cell populations within TB granulomas with unprecedented resolution. Their analyses revealed a startling downregulation of major histocompatibility complex class II (MHC II) molecules on macrophages situated in necrotic granulomas, accompanied by dampened activation of CD4+ T cells. This impaired molecular crosstalk between innate and adaptive immune cells suggests that the granuloma’s structural containment of Mtb masks a profound functional compromise at the cellular interface critical for robust immune defense. Essentially, the body’s own attempt to wall off infection paradoxically fosters an immunological stalemate that favors pathogen persistence.

The study’s innovative methodological approach combined spatial transcriptomics—a technology allowing gene expression profiling in intact tissue sections—with immunofluorescence microscopy, providing a detailed map of not only which immune cells were present but also their functional states and interactions in situ. This allowed the researchers to uncover how localized molecular environments within granulomas dictate macrophage behavior and influence T cell responses, revealing that necrotic regions within granulomas were hotspots of immune dysfunction.

Delving deeper, the team pinpointed a pathological accumulation of cholesterol in infected macrophages at the heart of the compromised antigen presentation observance. Using both human tissue samples and mouse models, they showed that Mtb infection—or exposure to pathogen-associated lipids such as mycolic acids—disrupted normal cholesterol trafficking pathways, resulting in excessive cholesterol storage within lysosomes. This lysosomal cholesterol overload sequestered MHC II molecules away from the cell surface, effectively silencing the macrophage’s capacity to present Mtb antigens to CD4+ T cells. Without proper antigen presentation, effective activation and proliferation of pathogen-specific T cells are blunted, undermining one of the immune system’s most potent weapons against intracellular pathogens.

This novel mechanistic insight connects lipid metabolism directly to immune evasion strategies employed by Mtb within granulomas. It establishes a previously unappreciated axis: Mtb-induced cholesterol accumulation hijacks the macrophage’s antigen presentation machinery, transforming the very cells tasked with orchestrating an immune attack into immunological blind spots. This discovery not only clarifies longstanding questions about the heterogeneity of granuloma responses but also identifies a potentially druggable metabolic checkpoint.

Encouragingly, the scientific team demonstrated that pharmacological interventions aimed at restoring cholesterol homeostasis could reinvigorate macrophage antigen presentation. Treating late-stage TB-infected mice with agents that modulate cholesterol trafficking pathways improved MHC II availability on macrophages and enhanced CD4+ T cell activation within granulomas. This therapeutic strategy led to a pronounced reduction in bacterial load, indicating that targeting the lipid dysregulation axis can shift the immune environment from a stalemate toward efficient bacterial clearance.

The implications of these findings extend beyond fundamental TB biology, offering a translational framework to inform novel host-directed therapies. By focusing on correcting host metabolic dysfunctions induced by Mtb, rather than directly targeting the bacterium, new treatments may avoid typical drug resistance pitfalls. Moreover, harnessing spatial transcriptomics and high-resolution imaging to study granuloma biology establishes a powerful blueprint for dissecting complex host-pathogen interactions in situ across diverse infectious diseases.

Crucially, the study sheds new light on the enigmatic nature of necrotic granulomas, which have long been associated with poor prognosis and treatment failure in TB. The researchers’ results suggest that necrosis marks areas where cholesterol-induced immune paralysis is most severe, providing a specific biomarker and mechanistic rationale for targeting these granuloma subregions therapeutically. This refined spatial understanding could lead to precision medicine approaches that tailor interventions based on granuloma phenotype and metabolic status.

Furthermore, the discovered link between mycolic acid exposure and cholesterol accumulation deepens our understanding of Mtb’s multifaceted strategies to evade immune detection. Mycolic acids, key lipid components of the mycobacterial cell wall, appear not only to contribute to structural integrity and virulence but also to actively modulate host cell lipid metabolism in a manner that sabotages normal immune signaling. This highlights the sophisticated interplay between pathogen-derived molecules and host immune regulation, emphasizing the need to consider lipid metabolism as an integral component of host-pathogen dynamics.

The study also prompts a reassessment of the role of macrophage subsets within granulomas. By spatially defining cells with impaired MHC II expression, the research identifies functionally specialized niches within these immune microstructures, where macrophages transition to states of antigen presentation incompetence. Unraveling the molecular cues that direct this phenotypic shift could reveal additional therapeutic targets to modulate macrophage plasticity and restore immune functionality.

Importantly, this work underscores the value of combining human clinical samples with animal models to validate pathophysiological mechanisms relevant to human disease. The alignment of findings from spatial transcriptomics in human lung tissue with mechanistic mouse model experiments strengthens the relevance and translatability of the conclusions. It also demonstrates how emerging technologies can forge new paths in understanding infectious diseases that have historically been challenging due to their complexity and heterogeneity.

Beyond tuberculosis, these insights about lipid metabolism’s impact on antigen presentation may have broader relevance to other chronic infections and inflammatory diseases characterized by granulomatous inflammation. Aberrant cholesterol handling and lysosomal dysfunction have been implicated in conditions such as leprosy, sarcoidosis, and even certain cancers, suggesting that the lessons gleaned from TB granulomas might inform a wider biomedical context.

Looking forward, the identification of cholesterol overload as a key disruptor of macrophage–T cell crosstalk invites further investigation into host-directed pharmacological agents capable of precise metabolic modulation. Additionally, exploring how other lipid species and metabolic pathways intersect with immune cell function within granulomas may yield a more holistic picture of the immunometabolic landscape dictating disease outcomes.

This innovative study by Chai et al. thus offers a paradigm shift in our understanding of TB pathogenesis, emphasizing that granulomas’ protective function is not solely structural but deeply influenced by metabolic regulation of immune interactions. Their work paves the way for novel therapeutic approaches that augment host immunity by targeting intracellular lipid metabolism, a promising avenue to enhance treatment efficacy against one of humanity’s most enduring infectious foes.

As the global burden of tuberculosis persists despite existing antibiotic regimens, strategies that harness these new insights into granuloma biology and immune-metabolic crosstalk could revolutionize interventions. By revitalizing immune defenses at the site of infection through metabolic modulation, we may ultimately tip the scales in favor of the host, offering fresh hope in the fight against this ancient yet resilient disease.

Subject of Research:
Detailed immunological and metabolic mechanisms underlying immune dysfunction within tuberculosis granulomas, focusing on cholesterol accumulation in macrophages and its impact on antigen presentation and CD4+ T cell activation.

Article Title:
Lipid accumulation in tuberculosis granulomas inhibits macrophage–CD4+ T cell interactions and infection control

Article References:
Chai, Q., Lu, Z., Zhao, M. et al. Lipid accumulation in tuberculosis granulomas inhibits macrophage–CD4+ T cell interactions and infection control. Nat Microbiol (2026). https://doi.org/10.1038/s41564-026-02317-3

Image Credits:
AI Generated

DOI:
https://doi.org/10.1038/s41564-026-02317-3